J D Crissman
Overview
Explore the profile of J D Crissman including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
166
Citations
2112
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
deVere White R, Deitch A, Tesluk H, Blumensteinj B, Lowe B, Sagalowsky A, et al.
Urol Oncol
. 2011 Jan;
2(1):27-34.
PMID: 21224132
While 80% of transitional cell carcinomas (TCC) present as Ta Tl lesions, they account for only 15% of deaths caused by TCC. We have evaluated the ability of DNA ploidy...
2.
Lamm D, Blumenstein B, Crawford E, Crissman J, Lowe B, Smith Jr J, et al.
Urol Oncol
. 2011 Jan;
1(3):119-26.
PMID: 21224104
To compare the toxicity and efficacy of intravesical bacillus Calmette-Guérin (BCG) immunotherapy and mitomycin C (MMC) chemotherapy in the prophylaxis of recurrent transitional cell carcinoma, 469 patients with completely resected...
3.
Kucuk O, Sarkar F, Sakr W, Djuric Z, Pollak M, Khachik F, et al.
Cancer Epidemiol Biomarkers Prev
. 2001 Aug;
10(8):861-8.
PMID: 11489752
An inverse association has been observed between dietary intake of lycopene and the risk of prostate cancer. We investigated the effects of lycopene supplementation in patients with prostate cancer. Twenty-six...
4.
Zarbo R, Barnes L, Crissman J, Gnepp D, Mills S
Hum Pathol
. 2001 Feb;
31(10):1191-3.
PMID: 11203319
No abstract available.
5.
deVere White R, Deitch A, Daneshmand S, Blumenstein B, Lowe B, Sagalowsky A, et al.
Eur Urol
. 2000 Apr;
37(5):595-600.
PMID: 10765099
Objectives: An intergroup study (SWOG 8795) comparing two forms of adjunctive therapy (immuno and chemo), bacillus Calmette-Guerin (BCG) and mitomycin C (MMC), furnished preregistration index tumors for 244 patients with...
6.
Lamm D, Blumenstein B, Crissman J, Montie J, Gottesman J, Lowe B, et al.
J Urol
. 2000 Mar;
163(4):1124-9.
PMID: 10737480
Purpose: Bacillus Calmette-Guerin (BCG) immunotherapy has been widely accepted as the optimal treatment for carcinoma in situ and high grade superficial transitional cell carcinoma. However, controversy remains regarding the role...
7.
Li L, Zhu Z, Joshi B, Zhang C, Johnson C, Marnett L, et al.
Anticancer Res
. 1999 May;
19(1A):61-9.
PMID: 10226525
Background: In the preceding paper, we demonstrated that, BMD188 [cis-1-hydroxy-4-(1-naphthyl)-6-octylpiperidine-2-one], a newly synthesized cyclic hydroxamic acid compound, induces potent apoptotic death of prostate cancer cells in vitro. In this project,...
8.
Visscher D, Gingrich D, Tabaczka P, Crissman J
Anal Cell Pathol
. 1999 Apr;
17(3):167-75.
PMID: 10221331
Two-color, multiparametric synthesis phase fraction (SPF) analysis of cytokeratin-labeled epithelial cells was flow cytometrically performed on both benign (SPFb) and malignant tissue samples (if available, SPFt) from 132 mastectomy/lumpectomy specimens....
9.
Bianco Jr F, Gervasi D, Tiguert R, Grignon D, Pontes J, Crissman J, et al.
Clin Cancer Res
. 1998 Dec;
4(12):3011-6.
PMID: 9865914
The matrix metalloproteinases (MMPs), in particular the gelatinases (MMP-2 and MMP-9) have been associated with tumor cell invasion and metastasis in many human cancers. Here we examined the expression of...
10.
Tang D, Li L, Zhu Z, Joshi B, Johnson C, Marnett L, et al.
Pathol Oncol Res
. 1998 Oct;
4(3):179-90.
PMID: 9761936
A newly synthesized cyclic hydroxamic acid compound, BMD188 [cis-1-hydroxy-4-(1-naphthyl)-6-octylpiperidine-2-one], was found to induce the apoptotic death of cultured prostate cancer cells by activating caspase-3. Orally administered BMD188 significantly inhibited the...